Neurology
Conference Coverage
Pediatric inpatient seizures treated quickly with new intervention
News
FDA approves Epidiolex for Lennox-Gastaut syndrome and Dravet syndrome
The approval, the first for a marijuana-derived pharmaceutical product, falls in line with the unanimous recommendation of an FDA advisory panel...
From the Journals
NIH launches HEAL Initiative to combat opioid crisis
HEAL will expand Advancing Clinical Trials in Neonatal Opioid Withdrawal Syndrome (ACT NOW), a pilot study that will assess the prevalence of...
Video
Pediatric MS gets a win with fingolimod
NASHVILLE, TENN. – First successful phase 3 study in pediatric MS may lead to a reshaping of the pediatric MS treatment paradigm.
Conference Coverage
Sulforaphane for autism? Maybe
LOS ANGELES –The dietary supplement is showing benefit in a small, ongoing trial, but there are a lot of pills.
Conference Coverage
Vestibular/oculomotor component of concussion warrants more attention
NEW ORLEANS – Positive findings on the Vestibular/Ocular Motor Screening (VOMS) assessment warrant referral for targeted rehabilitation using...
Conference Coverage
Myelin antibody predicts ADEM relapse
LOS ANGELES – Could results help to guide decisions on immunosuppressive treatment?
Conference Coverage
Guidance coming for mTOR inhibitors in infantile TSC
LOS ANGELES – Survey aimed to describe the wide variation in their off-label use, particularly in infants.
Conference Coverage
Multiple analgesia options for kids with acute pain
TORONTO – When analgesia is indicated, clinicians can choose from a variety of agents in the postcodeine era.
News
FDA expands fingolimod's indications to treat relapsing MS in pediatric patients
Among individuals who have MS, 2%-5% have symptoms onset before age 18.
Daily News Podcast
MDedge Daily News: Do HPV vaccines really cut cancer risk?
And Zika's had a costly effect on blood donor screening.